The following Conditions are related to Enlarged liver

Select a specific condition below to view its details.

  • Morquio disease

    Morquio disease is a rare inherited metabolic disorder in which the body has trouble processing specific kinds of sugar molecules (glycosaminoglycans). This condition, also known as mucopolysaccharidosis type IV (MPS IV), manifests as a skeletal disorder with aberrant spine curvature, a short neck, knock knees, and hip issues. Children who are affected by the syndrome may exhibit an expanded head and recognisable facial features. Infants with  Read More

  • Morquio syndrome

    The skeleton is typically affected by the uncommon genetic metabolic condition known as morquio syndrome. The specific GAG that accumulates in the body during Morquio Syndrome is known as keratan sulfate. This lysosomal storage disorder is a form of the autosomal recessive birth condition. GAG accumulation in many body regions results in symptoms in numerous organ systems. Treatment 1. Th  Read More

  • Phosphorylase kinase deficiency of liver

    Glycogen storage disease VIII is one of a group of hereditary disorders caused by a lack of one or more enzymes involved in glycogen synthesis or breakdown and characterized by deposition of abnormal amounts or types of glycogen in tissues. Excessive amounts of glycogen (which acts to store energy for later use) are deposited in the liver, causing it to become enlarged (hepatomegaly).  Read More

  • Torch syndrome

    TORCH Syndrome refers to infection of a developing fetus or newborn by any of a group of infectious agents. "TORCH" is an acronym meaning (T)oxoplasmosis, (O)ther Agents, (R)ubella (also known as German Measles), (C)ytomegalovirus, and (H)erpes Simplex. Infection with any of these agents (i.e., Toxoplasma gondii, rubella virus, cytomegalovirus, herpes simplex viruses) may cause a constellation of similar symptoms in affected newborns. These ma  Read More

  • Tyrosinemia, hereditary

    Tyrosinemia type I is a rare autosomal recessive genetic metabolic disorder characterized by lack of the enzyme fumarylacetoacetate hydrolase (FAH), which is needed for the final break down of the amino acid tyrosine. Failure to properly break down tyrosine leads to abnormal accumulation of tyrosine and its metabolites in the liver, potentially resulting in severe liver disease. Tyrosine may also accumulate in the kidneys and central nervous s  Read More